oral semaglutide for obesity FDA Approves Semaglutide: First GLP-1 Weight Loss Pill For patients with #obesity, semaglutide,

Some individuals feel nothing at all, while others notice mild discomfort that quickly resolves

It also acts as an antioxidant, protecting veins from damage caused by free radicals

NICE has begun welcoming longer-term real-world outcomes (via managed access) to reassess cost-effectiveness post-launch

doi:10.1001/jama.2021.1831 37

Baseline thyroid assessment before initiating GLP-1 therapy is clinically prudent for patients with Hashimoto's disease and should include thyroid-stimulating hormone (TSH) and free thyroxine (T4) levels to ensure the patient's hypothyroidism is adequately controlled on their current levothyroxine dose

With non-dilutive funding, business owners can worry less about losing ownership while still getting an infusion of R&D funding